Department of Oncology, The Medical Research Council Cancer Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdon;
Genes, Development, and Disease Group, Cancer Cell Biology Programme, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.
Genes Dev. 2016 Mar 1;30(5):489-501. doi: 10.1101/gad.276733.115.
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the adipose tissue. This systemic syndrome, termed cancer-associated cachexia (CAC), is a major cause of morbidity and mortality. While once attributed solely to decreased food intake, the present description of cancer cachexia is a disorder of multiorgan energy imbalance. Here we review the molecules and pathways responsible for metabolic dysfunction in CAC and the ideas that led to the current understanding.
代谢功能障碍导致晚期癌症患者临床状况恶化,其特征是体重减轻、骨骼肌消耗和脂肪组织萎缩。这种全身性综合征被称为癌症相关性恶病质(CAC),是发病率和死亡率的主要原因。虽然 CAC 曾一度被认为仅与食物摄入减少有关,但目前对癌症恶病质的描述是多器官能量失衡的一种疾病。本文综述了 CAC 代谢功能障碍相关的分子和途径,以及导致目前认识的相关思路。